Sequence Inversion to Facilitate Concurrent Radiotherapy and Systemic Therapy. A Proof of Principle Study in the Setting of a Phase II Randomized Trial in Prostate Cancer-Reference-Cited by-同舟云学术

Sequence Inversion to Facilitate Concurrent Radiotherapy and Systemic Therapy. A Proof of Principle Study in the Setting of a Phase II Randomized Trial in Prostate Cancer

Published:2020-09-30 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Wilke Derek,Wood Lori,Cwajna Slawa,Rutledge Robert,Hollenhorst Helmut,Bowes David,Patil Nikhilesh,Ago Casely T.,Pignol Jean-Philippe

Funder

Sanofi

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference18 articles.

1. Effect of chemotherapy with docetaxel with androgen suppression and radiotherapy for localized high-risk prostate cancer: the randomized phase III NRG oncology RTOG 0521 trial;Rosenthal;J Clin Oncol.,2019

2. Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial;Guttilla;Radiat Oncol Lond Engl.,2014

3. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: results of NRG Oncology/RTOG study 0621;Hurwitz;Cancer.,2017

4. A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy;Jackson;Adv Radiat Oncol.,2016

5. A phase II study evaluating bone marrow-sparing, image-guided pelvic intensity-modulated radiotherapy (IMRT) with cesium-131 brachytherapy boost, adjuvant chemotherapy, and long-term hormonal ablation in patients with high risk, nonmetastatic prostate cancer;Rice;Am J Clin Oncol.,2019